Reproductive biotechnology company Memphasys (ASX: MEM) has accelerated its FelixTM System sales orders in Japan, under its exclusive agreement with Vitrolife Japan KK, to sell and distribute the FelixTM System | ASX announcement: https://announcements.asx.com.au/asxpdf/20240318/pdf/061lr49l0r8k8h.pdf
DY6
0.165
292.9%
HCF
0.1
-71.4%
ERA
0.002
100%
AOF
0.485
-45.2%
MVP
0.615
32.3%
PAB
0.002
-33.3%
ADN
0.013
30%
SMX
0.02
-33.3%
ICR
0.009
28.6%
PGH
0.88
-19.6%
ID8
0.009
28.6%
QFE
0.061
-18.7%
PVT
0.009
28.6%
PNN
0.06
-16.7%
DTM
0.005
25%
SPX
0.005
-16.7%
WC1
0.016
23.1%
FBR
0.006
-14.3%
HMY
0.62
22.8%
HHR
0.006
-14.3%
OMX
0.039
21.9%
LMS
0.1
-13%
SLA
0.14
16.7%
LCL
0.007
-12.5%
G11
0.015
15.4%
ZEU
0.007
-12.5%
LDX
0.03
15.4%
SPA
0.18
-12.2%
VRL
0.015
15.4%
OSX
0.015
-11.8%
BSN
0.016
14.3%
29M
0.14
-9.7%
DTR
0.008
14.3%
IAM
0.019
-9.5%
SP8
0.008
14.3%
TMB
0.029
-9.4%
WNR
0.008
14.3%
AMN
0.051
-8.9%
JBY
0.645
13.2%
TVN
0.105
-8.7%
